A carregar...
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLCs). Expert consensus has defined minimum requirements for routine testing and identification of epidermal growth factor (EGFR) mutations (15% of tumors harbor EGFR exon...
Na minha lista:
| Publicado no: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933559/ https://ncbi.nlm.nih.gov/pubmed/26620497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815617871 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|